SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-003143
Filing Date
2020-09-16
Accepted
2020-09-16 07:00:12
Documents
25
Period of Report
2020-09-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cns_8k2.htm 8-K 20922
2 INVESTOR PRESENTATION cns_ex9901.htm EX-99.1 41008
3 GRAPHIC image_001.jpg GRAPHIC 174197
4 GRAPHIC image_002.jpg GRAPHIC 134591
5 GRAPHIC image_003.jpg GRAPHIC 164835
6 GRAPHIC image_004.jpg GRAPHIC 251955
7 GRAPHIC image_005.jpg GRAPHIC 131868
8 GRAPHIC image_006.jpg GRAPHIC 240903
9 GRAPHIC image_007.jpg GRAPHIC 232261
10 GRAPHIC image_008.jpg GRAPHIC 181457
11 GRAPHIC image_009.jpg GRAPHIC 246672
12 GRAPHIC image_010.jpg GRAPHIC 186988
13 GRAPHIC image_011.jpg GRAPHIC 178511
14 GRAPHIC image_012.jpg GRAPHIC 209896
15 GRAPHIC image_013.jpg GRAPHIC 266335
16 GRAPHIC image_014.jpg GRAPHIC 199100
17 GRAPHIC image_015.jpg GRAPHIC 265270
18 GRAPHIC image_016.jpg GRAPHIC 173971
19 GRAPHIC image_017.jpg GRAPHIC 269218
20 GRAPHIC image_018.jpg GRAPHIC 141738
21 GRAPHIC image_019.jpg GRAPHIC 156657
22 GRAPHIC image_020.jpg GRAPHIC 235223
23 GRAPHIC image_021.jpg GRAPHIC 179704
24 GRAPHIC image_022.jpg GRAPHIC 177436
25 GRAPHIC image_023.jpg GRAPHIC 174197
  Complete submission text file 0001683168-20-003143.txt   6364551
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 201177393
SIC: 2834 Pharmaceutical Preparations